OUR NEWS

FALGAGEN announces a strategic partnership with Defimedica, dialysis solutions’ specialist

The first independent services company expert in Hyaluronic Acid and Chitosan partners with Defimedica to serve their respective customers with innovative solutions. Annecy, March 2nd, 2021: Falgagen announced today the signature of a strategic partnership with the Swiss company Defimedica, to serve their respective customers with innovative solutions aiming to improve purification steps via dialysis…

Details

DERMAL FILLERS: A dynamic market which will finally not change face much…

Back from IMCAS 2020 in Paris, a short feedback for industry players and investors. Hyaluronic Acid is the star of dermal fillers and is not ready to leave its place to anything else, and probably this for long. Hyaluronic Acid fillers continues to tract the aesthetics market together with botulinum toxin, still for a certain…

Details

FALGAGEN CELEBRATES ITS FIRST ANNIVERSARY

On June 5th, 2019, we founded FALGAGEN.In the last 366 days, we have built up 9 partnerships with customers, with always the same idea in mind: set-up a healthy relationship with our partners. Healthy partnership means for us: a balanced approach of our mission where both teams are working together in transparency, and in full confidence…

Details

FALGAGEN, a newly formed Hyaluronic Acid & Chitosan consulting company, in the service of the industry

The first consulting & advisory company expert in HA and Chitosan  Annecy, July 15, 2019: Falgagen announces today the foundation of the first consulting and advisory company expert in HA and Chitosan, which serves the life sciences industries in the conception and development of Medical Devices comprising natural polymers, with a strong expertise in HA…

Details